Intralesional Treatments for Invasive Cutaneous Squamous Cell Carcinoma
Cancers · 28.12.2023 · 16 (1) · 158
DOI: 10.3390/cancers16010158 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 28.12.2023. Verfasst von Gloria Baeza-Hernández und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Complejo Asistencial Universitario de Salamanca, Paseo San Vicente 58-182, 37007 Salamanca, Spain. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Gerencia Regional de Salud de Castilla y León.
Abstract (Originalsprache)
Cutaneous squamous cell carcinoma (cSCC) is the second most frequent cancer in humans and has the potential to progress locally, metastasize, and cause death in a subset of patients. cSCC is especially common in the elderly, and it will probably represent a major health concern in the near future. Surgery is the standard treatment for cSCC, but intralesional therapies can sometimes be considered for certain patients and under certain circumstances. The choice of intralesional treatment depends on the patient′s characteristics and the clinician′s previous experience and expertise. Here we are reviewing intralesional treatments for cSCC and keratoacanthoma (KA). We have started with some classic drugs, such as methotrexate and 5-fluorouracil, bleomycin, interferon, and cryosurgery, but also comment on electrochemotherapy. Finally, we have focused on novel therapies, some of which are under development, and future perspectives, including intralesional immunotherapy and oncolytic viruses.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Complejo Asistencial Universitario de Salamanca, Paseo San Vicente 58-182, 37007 Salamanca, Spain.
- Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Centro de Investigación del Cáncer (CIC)-CSIC, Laboratory 20, 37008 Salamanca, Spain.
- Instituto de Investigación Biomédica de Salamanca (IBSAL), Complejo Asistencial Universitario de Salamanca, Paseo San Vicente 58-182, Hospital Virgen de la Vega, 10ª Planta, 37007 Salamanca, Spain.
ORCID-Profile: Gloria Baeza-Hernández, Javier Cañueto
Förderung
- Instituto de Salud Carlos III
- Gerencia Regional de Salud de Castilla y León
Zitieren
APA
Baeza-Hernández, G., & Cañueto, J. (2023). Intralesional Treatments for Invasive Cutaneous Squamous Cell Carcinoma. Cancers, 16(1), 158. https://doi.org/10.3390/cancers16010158
Vancouver
Baeza-Hernández G, Cañueto J. Intralesional Treatments for Invasive Cutaneous Squamous Cell Carcinoma. Cancers. 2023;16(1):158. doi:10.3390/cancers16010158
BibTeX
@article{BaezaHernndez2023,
author = {Baeza-Hernández, Gloria and Cañueto, Javier},
title = {Intralesional Treatments for Invasive Cutaneous Squamous Cell Carcinoma},
journal = {Cancers},
year = {2023},
volume = {16},
number = {1},
pages = {158},
doi = {10.3390/cancers16010158}
}
EUVIMED